Topical tretinoin cream for hyperpigmentation of face
tretinoin hyperpigmentation face topical
tretinoin topical retinoid hyperpigmentation melasma face before after
| Product | Concentration |
|---|---|
| Retin-A / Retin-A Micro | 0.025%, 0.05%, 0.1% cream/gel |
| Renova | 0.02%, 0.05% cream (photoaging) |
| Avita | 0.025% cream/gel |
Hydroquinone 4% + Tretinoin 0.05% + Fluocinolone acetonide 0.01%
| Step | Instruction |
|---|---|
| Timing | Apply in the evening only (UV light inactivates tretinoin) |
| Skin prep | Apply to dry skin (waiting 20-30 min after washing reduces irritation) |
| Amount | Pea-sized amount for the entire face |
| Frequency | Start 2-3x/week; increase to nightly as tolerated |
| Sunscreen | Mandatory daily broad-spectrum SPF 30+ (tretinoin increases photosensitivity) |
| Onset | Beneficial effects typically begin at 8-12 weeks; full results at 6-12 months |
| Effect | Details |
|---|---|
| Retinoid dermatitis | Erythema, peeling, dryness, burning - most common in first 4-6 weeks |
| Photosensitivity | Mandatory sun protection required |
| Post-inflammatory hyperpigmentation (PIH) | Paradoxically, irritation from tretinoin can worsen hyperpigmentation, especially in darker skin types (Fitzpatrick IV-VI) |
| Teratogenicity | Contraindicated in pregnancy (Category X) - despite low systemic absorption, tretinoin is a retinoid |
| Agent | Mechanism | Relative Efficacy for Hyperpigmentation |
|---|---|---|
| Tretinoin | Tyrosinase inhibition, cell turnover, melanosome transfer inhibition | Moderate; best in combination |
| Hydroquinone | Tyrosinase inhibition + melanosome degradation | High (gold standard for epidermal pigmentation) |
| Azelaic acid 15-20% | Weak competitive tyrosinase inhibitor | Mild-moderate; well-tolerated; good for PIH in sensitive skin |
| Adapalene | Similar retinoid mechanism, milder | Comparable but better tolerated; preferred in sensitive patients who cannot tolerate tretinoin |
| Tranexamic acid | Inhibits UV-induced plasminogen activation, reduces melanogenesis | Effective for melasma, especially oral/intradermal |
| Glycolic acid peels | Exfoliation + tyrosinase inhibition | Best as adjunctive therapy |
Which should i use tretin 0.1 or 0.05 or 0.025
What is your skin tone / Fitzpatrick type? · How sensitive is your skin? · Have you used tretinoin or any retinoid before?
| Concentration | Best For | Your Situation |
|---|---|---|
| 0.025% | Retinoid beginners, very sensitive or dark skin | Too low for you - you've tolerated retinoids before |
| 0.05% ✅ | Experienced users, medium skin, hyperpigmentation | Your ideal starting point |
| 0.1% | Experienced users with stubborn photoaging/acne, fair/tolerant skin | Reasonable next step but higher PIH risk for Fitzpatrick III-IV |
Can i use tretinoin with absolute radiance serum together
Absolute Radiance serum ingredients full list
| Ingredient | Compatible with Tretinoin? | Notes |
|---|---|---|
| Niacinamide | ✅ Excellent | Actually reduces tretinoin irritation and adds complementary brightening. One of the best companions for tretinoin |
| Alpha-Arbutin | ✅ Good | Complements tretinoin's anti-pigmentation effect via a different pathway (tyrosinase inhibition). No conflict |
| Diglucosyl Gallic Acid | ✅ Fine | Antioxidant brightener, no known interaction with tretinoin |
| Tetrahydrocurcumin | ✅ Fine | Antioxidant, anti-inflammatory - may even buffer mild tretinoin irritation |
| Allantoin | ✅ Beneficial | Soothing agent, helps calm the skin barrier alongside tretinoin |
| Fragrance | ⚠️ Caution | On tretinoin-sensitized skin, fragrance can cause irritation. Watch for redness or stinging |
Does being overweight or obese predispose to gynaecomastia
"The prevalence of gynecomastia increases with age and body mass index (BMI), likely because of increased aromatase activity in adipose tissue."
- Harrison's Principles of Internal Medicine, 22nd Ed. (2025)
↑ Body fat (obesity)
↓
↑ Peripheral aromatase activity in adipose tissue
↓
↑ Conversion of androgens → estrogens
↓
↑ Estrogen / androgen ratio
↓
Estrogen stimulates ductal proliferation in male breast tissue
↓
True gynecomastia (glandular tissue enlargement)
| True Gynecomastia | Pseudogynecomastia (Lipomastia) | |
|---|---|---|
| Tissue type | Glandular breast tissue | Adipose tissue only |
| Feel on exam | Firm, fibrous, cord-like, often tender | Soft, fatty, no distinct subareolar disc |
| Location | Subareolar, concentric disc >2 cm | Diffuse chest fat |
| Obesity link | Yes - via aromatase mechanism | Yes - directly (more fat deposited) |
| Hormonal basis | Yes | No |
Can we give 200 mg hydrocortisone injection for hornet sting to reduce swelling from progressing if 100 mg didn’t work
hydrocortisone 200mg dose anaphylaxis severe allergic reaction guidelines
| Source | Adult Hydrocortisone Dose |
|---|---|
| Tintinalli's Emergency Medicine | 250-500 mg IV (second-line, after epinephrine) |
| UK Resuscitation Council (2021) | 200 mg IV as initial dose |
| MSF Medical Guidelines | 100-200 mg (adults), repeatable every 6-8 hours |
| AAFP Practical Guide to Anaphylaxis | ~250 mg IV (5 mg/kg), repeatable every 6 hours |
| Feature | Local Reaction | Anaphylaxis/Systemic |
|---|---|---|
| Swelling limited to sting site | ✅ | May be present |
| Urticaria beyond sting site | ❌ | ✅ |
| Throat tightness, stridor | ❌ | ✅ |
| Wheeze, dyspnoea | ❌ | ✅ |
| Hypotension, dizziness | ❌ | ✅ |
| Nausea, vomiting, abdominal pain | ❌ | ✅ |
Step 1: Epinephrine IM 0.3-0.5 mg (if systemic features present) - FIRST LINE
Step 2: Hydrocortisone 200-250 mg IV slow push
Step 3: Diphenhydramine 25-50 mg IV/IM (H1 blocker)
Step 4: Ranitidine/famotidine IV (H2 blocker) - additive benefit
Step 5: Repeat hydrocortisone 100-200 mg IV every 6-8 hours if needed
Step 6: Oral prednisolone 40-60 mg/day for 3-5 days on discharge
Can we give injection avil as iv undiluted
injection Avil pheniramine maleate IV undiluted administration guidelines side effects
https://medicalguidelines.msf.org/en/viewport/EssDr/english/…
pheniramine maleate IV injection "slow intravenous" OR "diluted" OR "undiluted" prescribing information
"Intramuscular or slow intravenous injection"
| Risk | Mechanism |
|---|---|
| Hypotension / cardiovascular collapse | Rapid alpha-blockade and vasodilation from fast delivery |
| CNS toxicity / seizures | High peak plasma concentration from bolus effect |
| Excessive sedation / respiratory depression | Potent CNS depressant effect, compounded by rapid Cmax |
| Anticholinergic toxicity | Pheniramine has significant antimuscarinic activity - fast delivery amplifies this |
| Local vein irritation / thrombophlebitis | Concentrated solution is irritating to venous endothelium |
| Route | Safety | Speed of Action | Notes |
|---|---|---|---|
| IM | ✅ Safest | 15-20 min | Preferred in most settings |
| Slow IV (diluted) | ✅ Safe if done correctly | 5-10 min | Dilute in 10-20 mL NS, give over 5-10 min |
| Slow IV (undiluted) | ⚠️ Acceptable only if very slow | 5-10 min | Only if no saline available; give over minimum 5 min |
| Fast IV bolus (undiluted) | ❌ Dangerous | Immediate | Risk of collapse, seizures, severe hypotension |
What are pde6 inhibitors
PDE6 inhibitors phosphodiesterase 6 retina phototransduction clinical significance
How do sildenafil and tadalafil differ in PDE6 inhibition?